Senhwa Biosciences, Inc. (6492.TWO)
TWD 35.1
(-9.88%)
TWD 35.1
(-9.88%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -296.3 Million TWD | 15.25% |
| 2022 | -349.63 Million TWD | -6.19% |
| 2021 | -329.25 Million TWD | 7.22% |
| 2020 | -354.87 Million TWD | 9.34% |
| 2019 | -391.42 Million TWD | -4.14% |
| 2018 | -375.85 Million TWD | -1.06% |
| 2017 | -371.89 Million TWD | -45.83% |
| 2016 | -255.01 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -69.65 Million TWD | -10.3% |
| 2024 Q1 | -63.14 Million TWD | 24.46% |
| 2023 Q3 | -75.14 Million TWD | -16.64% |
| 2023 Q1 | -73.15 Million TWD | 20.34% |
| 2023 Q2 | -64.42 Million TWD | 11.94% |
| 2023 Q4 | -83.59 Million TWD | -11.25% |
| 2023 FY | -296.3 Million TWD | 15.25% |
| 2022 Q2 | -97.59 Million TWD | -25.72% |
| 2022 FY | -349.63 Million TWD | -6.19% |
| 2022 Q4 | -91.82 Million TWD | -11.19% |
| 2022 Q3 | -82.58 Million TWD | 15.38% |
| 2022 Q1 | -77.62 Million TWD | 5.95% |
| 2021 FY | -329.25 Million TWD | 7.22% |
| 2021 Q4 | -82.53 Million TWD | 5.3% |
| 2021 Q3 | -87.15 Million TWD | 0.0% |
| 2020 FY | -354.87 Million TWD | 9.34% |
| 2019 FY | -391.42 Million TWD | -4.14% |
| 2018 FY | -375.85 Million TWD | -1.06% |
| 2017 FY | -371.89 Million TWD | -45.83% |
| 2016 FY | -255.01 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | -472.218% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 218.044% |
| Level Biotechnology Inc. | 62.9 Million TWD | 571.037% |
| Sagittarius Life Science Corp | -55.03 Million TWD | -438.356% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | -358.359% |
| TaiMed Biologics Inc. | -194.81 Million TWD | -52.1% |
| GlycoNex Incorporation | -178.36 Million TWD | -66.126% |
| VBI | -6.6 Million TWD | -4388.805% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | -78.208% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -2673.881% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -676.239% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | -76.303% |
| Visgeneer Inc. | -19.58 Million TWD | -1412.614% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 56.607% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 147.355% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 509.262% |
| Neith Corporation | -40.03 Million TWD | -640.154% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 74.453% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -4800.05% |
| Enimmune corporation | -223.74 Million TWD | -32.431% |
| TaiRx, Inc. | -212.29 Million TWD | -39.575% |
| CHO Pharma, Inc. | -306.08 Million TWD | 3.195% |
| EirGenix Inc. | -915.2 Million TWD | 67.624% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 695.674% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | -367.95% |
| Lin BioScience, Inc. | -687.19 Million TWD | 56.882% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | -89.545% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 1400.044% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | -304.32% |
| Lukas Biomedical Inc. | -47.35 Million TWD | -525.739% |
| RBC Bioscience Corporation | 6.43 Million TWD | 4708.18% |
| BiOptic Inc. | 37.74 Million TWD | 884.979% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 56.934% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -697.272% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | -381.485% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 207.815% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | -221.687% |
| NaviFUS Corp. | -65.72 Million TWD | -350.799% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | -236.371% |
| Sinew Pharma Inc. | -170.92 Million TWD | -73.358% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | -334.728% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 326.769% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | -24.477% |
| AP Biosciences Inc | -339.29 Million TWD | 12.67% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 47.21% |
| 3D Global Biotech Inc. | -57.95 Million TWD | -411.304% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 3604.092% |
| Intech Biopharm Corporation | -337.98 Million TWD | 12.332% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 77.431% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -474.092% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | -73.6% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 154.933% |
| TCI GENE Inc. | 11.67 Million TWD | 2638.388% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | -132.309% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | -36.225% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 3027.925% |
| PharmaEngine, Inc. | 274.65 Million TWD | 207.885% |
| Savior Lifetec Corporation | 30.03 Million TWD | 1086.7% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 316.707% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 71.685% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | -136.39% |
| Acepodia, Inc. | -817.31 Million TWD | 63.747% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 39.338% |